Compare PBR & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBR | SYK |
|---|---|---|
| Founded | 1953 | 1941 |
| Country | Brazil | United States |
| Employees | 50687 | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.0B | 109.3B |
| IPO Year | N/A | 1994 |
| Metric | PBR | SYK |
|---|---|---|
| Price | $17.76 | $301.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $17.56 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 15.6M | 2.8M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.31% | 1.12% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $18.00 | $9.80 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | ★ $13.55 | $158.37 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $11.32 | $281.00 |
| 52 Week High | $22.24 | $404.87 |
| Indicator | PBR | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 28.42 | 45.23 |
| Support Level | $11.49 | $281.00 |
| Resistance Level | $22.15 | $375.26 |
| Average True Range (ATR) | 0.39 | 7.47 |
| MACD | -0.19 | 0.33 |
| Stochastic Oscillator | 2.97 | 35.69 |
Petrobras is a Brazil-based integrated energy company controlled by the Brazilian government. The company focuses on the exploration and production of oil and gas in Brazilian offshore fields. Production in 2025 was 3.0 million barrels of oil equivalent per day (80% oil), and reserves stood at 12.1 billion boe (84% oil). At the end of 2025, Petrobras operated 10 refineries in Brazil with a capacity of 1.8 million barrels per day and distributed refined products and natural gas throughout the country.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.